Search Results

2,871 articles with title/keywords/abstract containing tyrosine kinase inhibitor

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days Structural Analysis of DFG-in and DFG-out Dual Src-Abl Inhibitors Sharing a Common Vinyl Purine Template

Authors: Zhou, Tianjun; Commodore, Lois; Huang, Wei-Sheng; Wang, Yihan; Sawyer, Tomi K.; Shakespeare, William C.; Clackson, Tim; Zhu, Xiaotian; Dalgarno, David C.

Source: Chemical Biology & Drug Design, Volume 75, Number 1, January 2010 , pp. 18-28(11)

Publisher: Blackwell Publishing

Content loaded within last 14 days Apparent Remission of a Solitary Metastatic Pulmonary Lesion in a Liver Transplant Recipient Treated with Sorafenib

Authors: Yeganeh, M.; Finn, R. S.; Saab, S.

Source: American Journal of Transplantation, Volume 9, Number 12, December 2009 , pp. 2851-2854(4)

Publisher: Blackwell Publishing

Content loaded within last 14 days Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors

Authors: Krause, Mechthild; Gurtner, Kristin; Deuse, Yvonne; Baumann, Michael

Source: International Journal of Radiation Biology, Volume 85, Number 11, November 2009 , pp. 943-954(12)

Publisher: Informa Healthcare

Content loaded within last 14 days IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II

Authors: Zahradka, Peter; Storie, Benjamin; Wright, Brenda

Source: Canadian Journal of Physiology and Pharmacology, Volume 87, Number 10, 1 October 2009 , pp. 805-812(8)

Publisher: NRC Research Press

Content loaded within last 14 days New Pharmacological Developments in the Treatment of Hepatocellular Cancer

Authors: Gusani, Niraj J.; Jiang, Yixing; Kimchi, Eric T.; Staveley-O'Carroll, Kevin F.; Cheng, Hua; Ajani, Jaffer A.

Source: Drugs, Volume 69, Number 18, 24 December 2009 , pp. 2533-2540(8)

Publisher: Adis International

Content loaded within last 14 days What is new in kidney cancer?

Author: Kirkali, Ziya

Source: Expert Review of Anticancer Therapy, Volume 9, Number 12, December 2009 , pp. 1753-1755(3)

Publisher: Expert Reviews

Eruptive Keratoacanthoma-Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors

Authors: SMITH, KATHLEEN J.; HALEY, HEATHER; HAMZA, SATE; SKELTON, HENRY G.

Source: Dermatologic Surgery, Volume 35, Number 11, November 2009 , pp. 1766-1770(5)

Publisher: Blackwell Publishing

Sunitinib: A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies

Authors: Papaetis, Georgios S.; Syrigos, Kostas N.

Source: BioDrugs, Volume 23, Number 6, 1 December 2009 , pp. 377-389(13)

Publisher: Adis International

Pazopanib: an antiangiogenic drug in perspective

Authors: Castaneda, Carlos A; Gomez, Henry L

Source: Future Oncology, Volume 5, Number 9, November 2009 , pp. 1335-1348(14)

Publisher: Future Medicine

Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma

Authors: Ozawa, Shigeyuki; Kato, Yasumasa; Ito, Shin; Komori, Reika; Shiiki, Naoto; Tsukinoki, Keiichi; Ozono, Satoru; Maehata, Yojiro; Taguchi, Takahide; Imagawa-Ishiguro, Yukari; Tsukuda, Mamoru; Kubota, Eiro; Hata, Ryu-Ichiro

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2202-2209(8)

Publisher: Blackwell Publishing

Triptolide abrogates oncogene FIP1L1-PDGFRα addiction and induces apoptosis in hypereosinophilic syndrome

Authors: Jin, Yanli; Chen, Qi; Lu, Zhongzheng; Chen, Bo; Pan, Jingxuan

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2210-2217(8)

Publisher: Blackwell Publishing

Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer

Authors: Merseburger, Axel S; Simon, Annika; Waalkes, Sandra; Kuczyk, Markus A

Source: Expert Review of Anticancer Therapy, Volume 9, Number 10, October 2009 , pp. 1429-1434(6)

Publisher: Expert Reviews

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

Authors: Hegedűs, C; Özvegy-Laczka, C; Apáti, Á; Magócsi, M; Német, K; Őrfi, L; Kéri, G; Katona, M; Takáts, Z; Váradi, A; Szakács, G; Sarkadi, B

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 1153-1164(12)

Publisher: Blackwell Publishing

Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells

Authors: Krauth, M.-T.; Mirkina, I.; Herrmann, H.; Baumgartner, C.; Kneidinger, M.; Valent, P.

Source: Clinical & Experimental Allergy, Volume 39, Number 11, November 2009 , pp. 1711-1720(10)

Publisher: Blackwell Publishing

Gefitinib: A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer

Authors: Sanford, Mark; Scott, Lesley J.

Source: Drugs, Volume 69, Number 16, 12 November 2009 , pp. 2303-2328(26)

Publisher: Adis International

Lapatinib in metastatic breast cancer

Authors: Frenel, J-S; Bourbouloux, E; Berton-Rigaud, D; Sadot-Lebouvier, S; Zanetti, A; Campone, M

Source: Women's Health, Volume 5, Number 6, November 2009 , pp. 603-612(10)

Publisher: Future Medicine

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A